Wyden Questions Pfizer on Lyrica Price Hikes

Drug Industry Daily
A A
Sen. Ron Wyden (D-Ore.), the ranking member of the Senate Finance Committee, is seeking an explanation for the steadily growing cost of Pfizer’s blockbuster drug Lyrica.

To View This Article:

Login

Subscribe To Drug Industry Daily